Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dihua Yu

Showing results (51-60 of 154) with videos related to

Pageof 16
Sort By:
Cancer Research|April 4, 2002
Combined anti-fetal liver kinase 1 monoclonal antibody and continuous low-dose doxorubicin inhibits angiogenesis and growth of human soft tissue sarcoma xenografts by induction of endothelial cell apoptosisLianglin Zhang, Dihua Yu, Daniel J Hicklin, et al.
Cancer Research|October 18, 2002
Enhanced sensitization to taxol-induced apoptosis by herceptin pretreatment in ErbB2-overexpressing breast cancer cellsSangkyou Lee, Wentao Yang, Keng-Hsueh Lan, et al.
Cancer|September 16, 2003
ErbB2 overexpression in human breast carcinoma is correlated with p21Cip1 up-regulation and tyrosine-15 hyperphosphorylation of p34Cdc2: poor responsiveness to chemotherapy with cyclophoshamide methotrexate, and 5-fluorouracil is associated with Erb2 overexpression and with p21Cip1 overexpressionWentao Yang, Kristine S Klos, Xiaoyan Zhou, et al.
Cancer|April 13, 2007
High prevalence of p53 exon 4 mutations in soft tissue sarcomaParimal Das, Dhanasekaran Kotilingam, Borys Korchin, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 8, 2017
Targeting Aberrant p70S6K Activation for Estrogen Receptor-Negative Breast Cancer PreventionXiao Wang, Jun Yao, Jinyang Wang, et al.
International Journal of Biological Sciences|July 7, 2023
Ribonuclease 1 Enhances Antitumor Immunity against Breast Cancer by Boosting T cell ActivationYing-Nai Wang, Heng-Huan Lee, Zhou Jiang, et al.
Cancer Research|February 15, 2018
Oncogenic Kinase-Induced PKM2 Tyrosine 105 Phosphorylation Converts Nononcogenic PKM2 to a Tumor Promoter and Induces Cancer Stem-like CellsZhifen Zhou, Min Li, Lin Zhang, et al.
Cancer Research|November 18, 2008
Ph.D. Training in cancer biologyFrank M Torti, Dario Altieri, James Broach, et al.
American Journal of Cancer Research|June 7, 2021
Boosting immune surveillance by low-dose PI3K inhibitor facilitates early intervention of breast cancerJinyang Wang, Yuan Zhang, Yi Xiao, et al.
Cancer Research|April 6, 2006
Selective inhibition of ErbB2-overexpressing breast cancer in vivo by a novel TAT-based ErbB2-targeting signal transducers and activators of transcription 3-blocking peptideMing Tan, Keng-Hsueh Lan, Jun Yao, et al.
Pageof 16

Showing results (51-60 of 154) with videos related to

Sort By:
Pageof 16
Cancer Research|April 4, 2002
Combined anti-fetal liver kinase 1 monoclonal antibody and continuous low-dose doxorubicin inhibits angiogenesis and growth of human soft tissue sarcoma xenografts by induction of endothelial cell apoptosisLianglin Zhang, Dihua Yu, Daniel J Hicklin, et al.
Cancer Research|October 18, 2002
Enhanced sensitization to taxol-induced apoptosis by herceptin pretreatment in ErbB2-overexpressing breast cancer cellsSangkyou Lee, Wentao Yang, Keng-Hsueh Lan, et al.
Cancer|September 16, 2003
ErbB2 overexpression in human breast carcinoma is correlated with p21Cip1 up-regulation and tyrosine-15 hyperphosphorylation of p34Cdc2: poor responsiveness to chemotherapy with cyclophoshamide methotrexate, and 5-fluorouracil is associated with Erb2 overexpression and with p21Cip1 overexpressionWentao Yang, Kristine S Klos, Xiaoyan Zhou, et al.
Cancer|April 13, 2007
High prevalence of p53 exon 4 mutations in soft tissue sarcomaParimal Das, Dhanasekaran Kotilingam, Borys Korchin, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 8, 2017
Targeting Aberrant p70S6K Activation for Estrogen Receptor-Negative Breast Cancer PreventionXiao Wang, Jun Yao, Jinyang Wang, et al.
International Journal of Biological Sciences|July 7, 2023
Ribonuclease 1 Enhances Antitumor Immunity against Breast Cancer by Boosting T cell ActivationYing-Nai Wang, Heng-Huan Lee, Zhou Jiang, et al.
Cancer Research|February 15, 2018
Oncogenic Kinase-Induced PKM2 Tyrosine 105 Phosphorylation Converts Nononcogenic PKM2 to a Tumor Promoter and Induces Cancer Stem-like CellsZhifen Zhou, Min Li, Lin Zhang, et al.
Cancer Research|November 18, 2008
Ph.D. Training in cancer biologyFrank M Torti, Dario Altieri, James Broach, et al.
American Journal of Cancer Research|June 7, 2021
Boosting immune surveillance by low-dose PI3K inhibitor facilitates early intervention of breast cancerJinyang Wang, Yuan Zhang, Yi Xiao, et al.
Cancer Research|April 6, 2006
Selective inhibition of ErbB2-overexpressing breast cancer in vivo by a novel TAT-based ErbB2-targeting signal transducers and activators of transcription 3-blocking peptideMing Tan, Keng-Hsueh Lan, Jun Yao, et al.
Pageof 16